Not provided
Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| OT2HL158287 | U.S. NIH Grant/Contract | View source |
Not provided
Not provided
Withdrawn for study design changes prior to implementation of the study. No participants were enrolled.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| National Heart, Lung, and Blood Institute (NHLBI) | NIH |
| Massachusetts Community Engaged Alliance (MA-CEAL) | UNKNOWN |
Not provided
Not provided
Not provided
Not provided
This research is being conducted to investigate how to increase primary care health care visits and screenings and treatment for hypertension and diabetes in residents of housing developments in Boston. The investigators are partnering with Boston Housing Authority (BHA) and Trinity housing management to randomize 12 housing developments (6 in intervention and 6 in control). 6 residents from the housing developments will become Community Health Ambassadors (CHA). The CHAs will be trained to conduct "workshops" within the intervention arm. These workshops will cover Diabetes Mellitus (DM) and Hypertension (HTN) information. Along with the workshops, CHAs will act as mentors for the residents and provide them with resources to connect them to primary care, Community Health Centers, food pantry resources, how to get insurance, and other needed services. CHAs will be part-time employees of the Massachusetts Community Engaged Alliance (MA-CEAL), so they will be paid for the work they are doing while simultaneously building their professional skill set.
MA-CEAL's community engagement (CE) team will act as liaisons and mentors for the CHA's to help guide them and also connect them to opportunities for career/personal development.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Intervention (Phase A) | Experimental | Community health centers randomized into this arm will receive study interventions in the first 18 months of the study. |
|
| Control (Phase B) | Experimental | Community health centers randomized into this arm will be wait listed and will not receive study interventions during the first 18 months of the study. They will receive study interventions during the last 12 months of the study. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Educating participants about healthcare resources | Other | MA-CEAL team members, including the community health ambassador (CHA), will assist in connecting residents with healthcare resources. |
| Measure | Description | Time Frame |
|---|---|---|
| Number of primary care visits | Self-report primary care visits in the last 18 months will be obtained using selected items from the National Health Interview Survey (NHIS) | Baseline, 6 months, 12 months, 18 months |
| Measure | Description | Time Frame |
|---|---|---|
| Number of screenings for diabetes | Self-reported by participants in a study questionnaire | Baseline, 6 months, 12 months, 18 months |
| Number of screenings for hypertension | Self-reported by participants in a study questionnaire |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Benjamin Linas, MD MPH | Boston Medical Center, Infectious Disease | Principal Investigator |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D006973 | Hypertension |
| D003920 | Diabetes Mellitus |
| D010342 | Patient Acceptance of Health Care |
| ID | Term |
|---|---|
| D014652 | Vascular Diseases |
| D002318 | Cardiovascular Diseases |
| D044882 | Glucose Metabolism Disorders |
| D008659 | Metabolic Diseases |
Not provided
Not provided
A waitlist-control trial design will be used for this study. 6 of the 12 participating housing developments will be randomized into the intervention arm and 6 into the control arm. At month 0 all participants will participate in baseline activities (surveys). At month 18 the control arm will begin the intervention. The whole study is projected to take 36 months.
Not provided
Not provided
Not provided
Not provided
| Healthcare appointments | Other | MA-CEAL team members, including the community health ambassador (CHA), will assist residents in making physician appointments. |
|
| Workshops | Other | Trained CHAs will provide workshops with information about diabetes and hypertension and how to be screened and get care. |
|
| Baseline, 6 months, 12 months, 18 months |
| D009750 | Nutritional and Metabolic Diseases |
| D004700 | Endocrine System Diseases |
| D000074822 | Treatment Adherence and Compliance |
| D015438 | Health Behavior |
| D001519 | Behavior |